insights_auto
Why is CSBR down 3.30%?
Dive Deeperchevron_right
CSBR:NASDAQ
Champions Oncology Inc
$4.44
arrow_downward
-3.30%(-0.15) 1D
Nov 18, 4:00:00 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CSBR...
Open
$4.55
High
$4.60
Low
$4.41
Mkt. cap
61.82M
Avg. vol.
7.41K
Volume
11.73K
52-wk high
$8.31
52-wk low
$4.41
EPS
-$0.08
Beta
0.47
Shares outstanding
13.92M
No. of employees
217
Open
$4.55
High
$4.60
Low
$4.41
Mkt. cap
61.82M
Avg. vol.
7.41K
Volume
11.73K
52-wk high
$8.31
52-wk low
$4.41
EPS
-$0.08
Beta
0.47
Shares outstanding
13.92M
No. of employees
217
News stories
From web sources and news partners
ChartMill
·
1 hour ago
S&P 500 Postmarket Gainers: PANW, CRWD and OKTA Extend After-Hours Gains
FXStreet
·
47 minutes ago
Dow Jones Industrial Average drops as UnitedHealth and Nvidia fall
The Motley Fool
·
27 minutes ago
Stock Market Today, Nov. 18: S&P 500 Breaks Key Support as Fed Minutes Signal More Rate Hikes Ahead
Traders Union
·
1 hour ago
Peter Tuchman: S&P 500 loses $2.5 trillion in market cap over five days
Profile
Champions Oncology is an American technology company that develops mouse avatars. Called TumorGrafts, they are used to test a panel of chemotherapy regimens, targeted therapies and monoclonal antibodies to identify potential therapeutic options for cancer patients. The company was founded in 2007 by David Sidransky, M.D., a Johns Hopkins University oncologist. Wikipedia
About Champions Oncology Inc
CEO-
Employees217
Founded2007
HeadquartersHackensack, New Jersey, United States
SectorHealth Care
Industry-
Websitechampionsoncology.com